Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity


SOLAY A. H. , ACAR A., ESER F., KUŞCU F. , TUTUNCU E. E. , KUL G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.29, ss.561-565, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 29 Konu: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/tjg.2018.18032
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Sayfa Sayısı: ss.561-565

Özet

Background/Aims: Tumor necrosis factor-alpha (TNF-alpha) inhibitors and ustekunimab are widely used in autoimmune diseases. It is known that these biological agents cause the reactivation of hepatitis 8 virus (HBV). There is no standardized strategy to prevent the reactivation in patients with evidence of a previous HBV infection. In our study, anti-HBc IgG-positive patients who received a biological agent were evaluated in terms of HBV reactivation.